Ledger.Open graph →
SEC Form D · filed November 27, 2019

PDX Pharmaceuticals, Inc

Offering
$4.0M
Sold
$1.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PORTLAND, OR
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Angela Hult · PORTLAND, ORDirectorMichael Joblonski · Orlando, FLDirectorWassana Yantasee · PORTLAND, ORExec · DirectorJoe Gray · PORTLAND, ORDirectorWorapol Ngamcherdtrakul · PORTLAND, ORExecBryson Nobles · Mableton, GADirectorWassana Yantasee · PORTLAND, ORExec · DirectorJoe Gray · PORTLAND, ORDirectorWorapol Ngamcherdtrakul · PORTLAND, ORExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗